We analyze available clinical and other data to identify groups of patients who are “At-Risk” of needing major treatments in the future. Our AnaVis™ and EarlyManage™ families of fully HIPAA compliant products perform the tasks of identification and offering suitable treatment protocols as follows.
AnaVis™ identifies patients in the pre-acute stages of their illnesses. It is in the pre-acute stages when patients are still healthy enough to benefit from treatments at lower cost points.
EarlyManage™ delivers treatment protocols specifically tuned to the pre-acute stages of illnesses.
Using AnaVis™ & EarlyManage™ patient conditions may never escalate to the acute stages where it is more expensive to treat the same patient. Please see the illustration below.